Sleep Disorders Trial, Recruiting NCT04966351 Sponsor: Colorado State University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT04966351
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 35 years old, both men and women (with equal numbers of each)
  • People with a Body Mass Index (BMI) between 20.0 and 24.9, which is considered a "normal" weight range
  • People who are either not regularly active or only moderately active on a habitual basis
  • People who normally sleep between 7 and 9.25 hours per night
  • People who have been living at the altitude of Denver, Colorado or higher for at least 3 months before the inpatient part of the study

Who may not be able to join:

  • People who have any significant medical, mental health, or sleep condition
  • People who have used prescription medications, supplements, or illicit drugs in the month before the study
  • People who have done shift work in the year before the study, or who have travelled across more than one time zone in the three weeks before the study (note: the trial site may consider these individuals at a later date)
  • Women who have a history of gynaecological conditions, who gave birth less than one year ago, or who are currently breastfeeding or pregnant
  • People who do not speak English, as the trial site does not currently have access to a translator to support the consent process and study participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 9704913103

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Colorado State University
Registry
ClinicalTrials.gov
Start date
7 July 2021
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Insulin sensitivity-derived from glucose tolerance test; Muscle tissue lipids-assessed by lipidomic analyses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov